WO2017017676A1 - Device for non-intrusive and automated animal urine tests - Google Patents
Device for non-intrusive and automated animal urine tests Download PDFInfo
- Publication number
- WO2017017676A1 WO2017017676A1 PCT/IL2016/050815 IL2016050815W WO2017017676A1 WO 2017017676 A1 WO2017017676 A1 WO 2017017676A1 IL 2016050815 W IL2016050815 W IL 2016050815W WO 2017017676 A1 WO2017017676 A1 WO 2017017676A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- urinalysis
- urine
- animal
- test results
- analysis strip
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 73
- 238000009535 clinical urine test Methods 0.000 title description 7
- 238000002562 urinalysis Methods 0.000 claims abstract description 132
- 210000002700 urine Anatomy 0.000 claims abstract description 99
- 238000004458 analytical method Methods 0.000 claims abstract description 56
- 241000282465 Canis Species 0.000 claims abstract description 49
- 238000000034 method Methods 0.000 claims abstract description 34
- 238000012360 testing method Methods 0.000 claims description 74
- 239000000203 mixture Substances 0.000 claims description 27
- 239000005667 attractant Substances 0.000 claims description 20
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 18
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 17
- 230000031902 chemoattractant activity Effects 0.000 claims description 16
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 16
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 claims description 14
- BTXXTMOWISPQSJ-UHFFFAOYSA-N 4,4,4-trifluorobutan-2-one Chemical compound CC(=O)CC(F)(F)F BTXXTMOWISPQSJ-UHFFFAOYSA-N 0.000 claims description 12
- BQACOLQNOUYJCE-FYZZASKESA-N Abietic acid Natural products CC(C)C1=CC2=CC[C@]3(C)[C@](C)(CCC[C@@]3(C)C(=O)O)[C@H]2CC1 BQACOLQNOUYJCE-FYZZASKESA-N 0.000 claims description 12
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 12
- 239000003016 pheromone Substances 0.000 claims description 12
- 230000036541 health Effects 0.000 claims description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 9
- 229910021529 ammonia Inorganic materials 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- 239000008103 glucose Substances 0.000 claims description 8
- 210000000265 leukocyte Anatomy 0.000 claims description 8
- 229960001047 methyl salicylate Drugs 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 claims description 7
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- 230000027939 micturition Effects 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 6
- 239000013078 crystal Substances 0.000 claims description 6
- 238000002405 diagnostic procedure Methods 0.000 claims description 6
- 150000002576 ketones Chemical class 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 238000012124 rapid diagnostic test Methods 0.000 claims description 6
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 5
- 239000012790 adhesive layer Substances 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 5
- 239000004202 carbamide Substances 0.000 claims description 5
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 5
- 230000005484 gravity Effects 0.000 claims description 4
- 230000009471 action Effects 0.000 claims description 3
- 238000005286 illumination Methods 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- 238000007619 statistical method Methods 0.000 claims description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 21
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 8
- 238000012549 training Methods 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- 125000001931 aliphatic group Chemical group 0.000 description 6
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 6
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 230000029142 excretion Effects 0.000 description 5
- 229960003424 phenylacetic acid Drugs 0.000 description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 4
- -1 alkyl hydroxybenzoates Chemical class 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 4
- FGKJLKRYENPLQH-UHFFFAOYSA-N isocaproic acid Chemical compound CC(C)CCC(O)=O FGKJLKRYENPLQH-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- PGMYKACGEOXYJE-UHFFFAOYSA-N pentyl acetate Chemical compound CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 4
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 4
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 4
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 4
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 150000003902 salicylic acid esters Chemical class 0.000 description 3
- 241000894007 species Species 0.000 description 3
- HOLHYSJJBXSLMV-UHFFFAOYSA-N 2,6-dichlorophenol Chemical compound OC1=C(Cl)C=CC=C1Cl HOLHYSJJBXSLMV-UHFFFAOYSA-N 0.000 description 2
- MDRHCSMEPNRFJL-UHFFFAOYSA-N 2-methylbutanoic acid;3-methylbutanoic acid Chemical compound CCC(C)C(O)=O.CC(C)CC(O)=O MDRHCSMEPNRFJL-UHFFFAOYSA-N 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- 239000005711 Benzoic acid Chemical class 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- KSKHXBOOCXALSJ-UHFFFAOYSA-N acetamide;formamide Chemical compound NC=O.CC(N)=O KSKHXBOOCXALSJ-UHFFFAOYSA-N 0.000 description 2
- GFGJNFKDZWVYRW-UHFFFAOYSA-N acetic acid;propanoic acid Chemical compound CC(O)=O.CCC(O)=O.CCC(O)=O GFGJNFKDZWVYRW-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 210000003503 anal sac Anatomy 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- 229940043351 ethyl-p-hydroxybenzoate Drugs 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 239000003163 gonadal steroid hormone Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 2
- 229940033080 omega-6 fatty acid Drugs 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- OBHRVMZSZIDDEK-UHFFFAOYSA-N urobilinogen Chemical compound CCC1=C(C)C(=O)NC1CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(CC3C(=C(CC)C(=O)N3)C)N2)CCC(O)=O)N1 OBHRVMZSZIDDEK-UHFFFAOYSA-N 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- YBBLOADPFWKNGS-UHFFFAOYSA-N 1,1-dimethylurea Chemical compound CN(C)C(N)=O YBBLOADPFWKNGS-UHFFFAOYSA-N 0.000 description 1
- 208000000819 Adrenocortical Hyperfunction Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000014311 Cushing syndrome Diseases 0.000 description 1
- 206010063057 Cystitis noninfective Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020564 Hyperadrenocorticism Diseases 0.000 description 1
- 208000019025 Hypokalemia Diseases 0.000 description 1
- 206010021027 Hypomagnesaemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010023379 Ketoacidosis Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 241001504654 Mustela nivalis Species 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000010067 Pituitary ACTH Hypersecretion Diseases 0.000 description 1
- 208000020627 Pituitary-dependent Cushing syndrome Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 229940094957 androgens and estrogen Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000002642 gamma-glutamyl group Chemical group 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000003632 microfilament Anatomy 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 208000024896 potassium deficiency disease Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000010024 tubular injury Effects 0.000 description 1
- 208000037978 tubular injury Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K29/00—Other apparatus for animal husbandry
- A01K29/005—Monitoring or measuring activity, e.g. detecting heat or mating
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K23/00—Manure or urine pouches
- A01K23/005—Manure or urine collecting devices used independently from the animal, i.e. not worn by the animal but operated by a person
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B10/007—Devices for taking samples of body liquids for taking urine samples
Definitions
- the present invention relates to devices, methods and systems for the collection and analysis of animal urine, especially canine urine. More particularly, the present invention provides devices, methods and systems for rapid on-the-spot and rapid point-of-care analysis of animal urine, especially canine urine.
- Urine tests are a simple and effective tool for diagnosing multiple conditions and diseases in a patient- either human or non-human. Such conditions or diseases cause a change in the level of (increase or decrease), or the appearance of certain substances, and/or organisms, and/or biological/chemical biomarkers in the urine.
- urine tests are ordered for a multitude of reasons, ranging from periodic examinations, tracking during specific periods such as pregnancy, recuperation from various diseases, etc. The same basic idea holds true to urine tests in animals as well.
- the above mentioned first two options provide the veterinarian a sterile sample by avoiding the lower urinary tract and possible exposure to the outside.
- both methods can be performed only by a skilled artisan within a sterile environment, such as a doctor's or veterinarian's office.
- the 3 method namely mid-stream, can be performed by any untrained pet/animal owner with the risk of getting a sample that is not free of outside contaminants, which in most cases and tests is not relevant or has little to no effect on the test results.
- this mid-stream collection method is also unsanitary for the collector, which might come in contact with the animal's urine during the collection process.
- Table 1 lists exemplary common elements that can be analyzed in a canine urinalysis and their usefulness:
- Ketones Indicator of Ketoacidosis produced when fat is used for energy
- US 6,531,145 describes a method and device for luring, repelling and training animals by using scents.
- US 7,051,681 specifically describes an article useful for attracting canine.
- US 5,058,533 and US 5,415,131 disclose animal litter that is capable of attracting animals, e.g. for urinating and defecate at a specific area.
- US 5,287,826 describes a method and kit for encouraging dogs to urinate and defecate at a predetermined area using ⁇ -ionone.
- Pheromones are chemicals produced by an animal (or plant) to affect the behavior or physiology of another member of the same species.
- Examples of known pheromones are aliphatic n-acetates, such as n-pentyl acetate; aliphatic n-fatty acids, such as n-butyric acid; alkyl hydroxybenzoates, such as methyl p-hydroxybenzoate and ethyl p-hydroxybenzoate; substituted phenols, such as 2, 6-dichlorophenol; benzoic acid derivatives, such as p-hydroxybenzoic acid, 4-hydroxy-3-n-ethoxybenzaldehyde and methylparaben; salicylates, such as methyl salicylate; and linoleic acid (i.e. omega-6 fatty acid).
- aliphatic n-acetates such as n-pentyl acetate
- aliphatic n-fatty acids such as n-butyric acid
- Some commercial puppy pads are treated with a fresh grass scent to encourage puppies to use them.
- Several compounds associated with such a grass scent have been suggested to aid in canine attraction, such as ⁇ -ionone (C 13 H 20 O), abietic acid or decarboxylated abietic acid, which are the active substances in rosin oil, and methyl salicylate.
- an improved animal attraction composition especially canine attraction composition for aiding in both potty training as well as for other training purposes, such as for attracting and stimulating the animal to urinate at a specific spot.
- the present invention provides a non-invasive urinalysis portable device 10 for the carrying out of rapid diagnostic tests on animal urine samples, comprising: (i) an analysis strip 13 for carrying out said diagnostic tests, on which test result can be read; (ii) at least one opening 14 for displaying said test results; and (iii) means 12 for the collection of said urine and forwarding same to said analysis strip 13, wherein said analysis strip 13 comprises at least one testing reagent and/or sensor.
- said non-invasive urinalysis device is designed to be placed onto any surface, to attract said animal to urinate thereon, to collect said animal's urine and for forwarding same to said analysis strip 13 for urinalysis.
- the present invention provides a method for rapid urinalysis of animal urine samples by using the non-invasive urinalysis device 10 of the invention, said method comprising: (a) placing and/or attaching said urinalysis device 10 at/on a desired location; (b) attracting said animal to said device 10 by releasing said animal attraction composition from said attractant component 15 if present; (c) collecting and directing said animal's urine to said analysis strip 13 for urinalysis; (d) reading the urinalysis test results through said at least one opening 14 and analyzing same; (e) optionally, determining whether said analyzed data is indicative of occurrence of a health condition; and (f) optionally, following up on test result with an action such as communicating with the veterinarian, scheduling a follow-up exam, etc.
- the present invention provides a non-invasive urinalysis portable urinalysis system, said system comprising: (i) the non-invasive urinalysis portable device 10 of the invention; (ii) a mobile device comprising (i) a camera, (ii) one or more processors, and (iii) a memory; (iii) a database; and (iv) optionally, at least one illumination source.
- the present invention provides a canine attraction composition
- a canine attraction composition comprising any combination of: (a) at least one pheromone; (b) at least one of ammonia and urea, or derivatives thereof; and (c) at least one of: ⁇ -ionone (C 13 H 20 O); abietic acid; decarboxylated abietic acid; rosin oil; and methyl salicylate, wherein said composition is suitable for attracting canines and stimulate urination.
- Fig. 1 is a picture of a urinalysis test stick of the prior art and analysis card thereof.
- FIGs. 2A-2D are schematic drawings of four possible configurations of the urinalysis device of the invention (upper view).
- FIGs. 3A-3C are schematic drawings of three possible configurations of the urinalysis device of the invention (bottom view).
- FIGs. 4A-4D illustrate four possible placement manners of the urinalysis device of the invention for an animal to urinate thereon.
- FIG. 5 illustrates one possible urine collection manner using the urinalysis device of the invention placed at the end of an elongated stick.
- the present invention aims at solving all the disadvantages of the presently known devices and urinalysis kits.
- the present invention provides methods and devices for sampling pet's urine and immediate analysis thereof.
- the present invention further provides methods and devices for canine attraction and subsequent urination thereon in a dedicated location/spot, as well as for immediate analysis thereof.
- the present invention provides a non-invasive urinalysis portable device 10 for the carrying out of rapid diagnostic tests on animal urine samples, without the need of collecting the urine and transferring it to a dedicated urinalysis unit, said device 10 comprises: (i) an analysis strip 13 for carrying out said diagnostic tests, on which test result can be read; (ii) at least one opening 14 for displaying said test results, said opening may be either a part of the device (see e.g. 14 in Fig. 2A) or the entire face of the device (see e.g. 14 in Figs.
- said analysis strip 13 comprises at least one testing reagent and/or sensor
- said non-invasive urinalysis device is designed to be placed onto any surface, to attract said animal to urinate thereon, to collect said animal's urine and for forwarding same to said analysis strip 13 for urinalysis.
- said device 10 comprises multiple repetitive areas for performing the urinalysis, so that it is sufficient to contact only part of the device 10 with the urine in order to obtain complete urinalysis, thereby reducing the risk of the urine missing the testing area.
- the term "collection” and its abbreviations, refers to the action of collecting and/or sampling any amount of urine by using the urinalysis device 10 of the invention itself. Such collection is performed without exposing the user to the risk of unintentionally touching the pet's urine.
- the urinalysis portable device 10 of the invention further comprises a permeable upper surface 12 for enabling the urine to pass through and towards said analysis strip 13.
- Said permeable upper surface may be made of any suitable material, such as cotton, polymer, plastic, nylon, etc.
- said permeable upper surface may also direct the urine towards said analysis strip 13.
- the perimeter of the urinalysis device 10 of the invention has lifted edges 19 enabling collecting and containing an amount of urine sufficient for performing the urinalysis.
- a sufficient amount means any amount of urine that is needed for performing the urinalysis. In specific embodiments, a sufficient amount is as little as 0.5 cc urine. In other embodiments, a sufficient amount is 1, 1.5, 2, 2.5, 3, 5, 7.5, 10 cc urine or more.
- the urine is forwarded to said analysis strip 13 for urinalysis, by any suitable autonomous means, either passive or active.
- autonomous passive means are a layer of absorbing material 12, or a layer of micro-tubes.
- active means i.e. power-activated means, such as pumps and vacuum.
- the urinalysis device 10 of the invention further comprises a component or layer designed to direct the urine towards said analysis strip 13, such as microtubules, microfilaments, channels, etc.
- the urinalysis device 10 of the invention may further comprise an active urine means for polling or pushing the urine towards said analysis strip 13, such as a pump sucking or pushing the urine.
- the urinalysis portable device 10 of the invention is disposable, and is designed for a single use.
- the urinalysis portable device 10 of the invention further comprises an attractant component 15 containing an animal attraction composition.
- said attractant component 15 is not an integral part of said urinalysis device 10, but an add-on.
- Such an add-on may be in any suitable form, such as a sticker.
- said add-on may be a completely separate component, such as a breakable vial which its content is spilled onto said device 10 upon breakage of the vial; a spray canister, which is sprayed onto said device 10; or an ointment which is rubbed against or applied on said urinalysis device 10.
- the urinalysis device 10 of the invention further comprises an adhesive layer 16 or attachment means 17 for placing said device onto any surface or location and in any angle.
- Said adhesive layer 16 may cover the entire back surface of said urinalysis device 10 (see e.g. Fig. 3A) or may be located at specific points thereon (see e.g. Fig. 3B).
- Non- limiting examples of such an adhesive layer which enable attaching said urinalysis device 10 onto any surface, either smooth or rough, and in any angle and configuration are: adhesives, glue, two-sided scotch tape, etc.
- attachment means such as magnets, for attaching said device 10 to metal surfaces such as fire hydrate; nails/pins for attaching said device 10 to wood surfaces such as trees, wood floors, etc.; or stakes for attaching said device 10 to the soil/ground.
- the urinalysis device 10 of the invention may be used in various situations. For instance, it may simply be placed onto the ground (Fig. 4A); leaned on designated attachment means 17 (Fig. 4B); adjusted to curved or bent surfaces such as stairs (Fig. 4C); or vertically attached to a wall or tree (Fig. 4D).
- Fig. 4A a specific embodiment, illustrated in Fig.
- the urinalysis device 10 of the invention may further comprise as an integral part, or an add-on, a dedicated elongation device/unit 18, which enable the user to hold the urinalysis device 10 at any desired angle and location underneath the urinating animal/dog, thereby collecting its urine.
- a dedicated elongation device/unit 18 is a stick configuration (Fig. 5).
- the urinalysis device 10 of the invention is configured to enable the user to attach it onto a designated elongation device 18, thereby enabling the user to place said device 10 beneath the urinating animal from a distance for collection of urine mid-stream.
- the urinalysis device 10 comprises as an integral part thereof said elongation device 18.
- said elongation device 18 is extractable, thus enabling easy carrying around when folded, and simple opening, i.e. extraction to full length, before use.
- the urinalysis device 10 of the invention is designed to test canine urine. In another specific embodiment, the urinalysis device 10 of the invention is designed to test feline urine. In another specific embodiment, the urinalysis device 10 of the invention is designed to test ungulate urine, such as horses, cattle and pigs. In another specific embodiment, the urinalysis device 10 of the invention is designed to test weasel urine.
- the analysis strip 13 in the urinalysis device 10 of the invention comprises at least one testing reagent and/or sensor designed to detect the presence and/or amount of and/or analyze at least one of: blood, leukocytes, white blood cells, nitrite, glucose, ketones, protein, specific gravity (urine concentration), pH, bilirubin, casts, bacteria, and crystals.
- the urinalysis device 10 of the invention further comprises a power source and a transmitter for transmitting the urinalysis data to, e.g., a mobile device or to a remote computer, or both.
- the urinalysis device 10 of the invention further comprises a processor and a memory for analyzing the urinalysis data. Said analyzed data can then be either displayed onto said device 10, or transmitted to e.g., a mobile device or to a remote computer, or both.
- the urinalysis device 10 of the invention further comprises an indicator configured to indicate proper loading and/or sufficient amount of collected urine sample, and/or that the urinalysis has concluded. This enables the user to verify that the animal has urinated on the device and that sufficient amount of urine has been collected for analysis, and that the urinalysis is complete, thereby reducing to a minimum the possibility of misreading's due to insufficient urine for analysis.
- the urinalysis device 10 of the invention further comprises an indicator configured to indicate the presence of at least one faulty test in said analysis strip 13, thereby enabling the user to avoid faulty test results arising due to a bad analysis strip.
- said indicator may indicate the user that the device 10 is faulty prior to its use, thereby enabling the user to return and replace the device 10.
- the urinalysis device 10 of the invention further comprises a "timer" test designed to let the pet/animal owner that the urinalysis in the analysis strip 13 has been concluded and that it is possible to scan the results for analysis.
- the present invention also provides rapid urinalysis of animal urine samples methods by using a urinalysis device 10 according to the invention.
- the present invention provides a method for rapid urinalysis of animal urine samples by using a noninvasive urinalysis device 10 of the invention, said method comprising: (a) placing and/or attaching said urinalysis device 10 at or on a desired location, wherein said location may be flattened such as a pavement (see, e.g., Fig. 4A), curved or bent such as un-even ground, or may be vertical such as a tree (see, e.g., Fig.
- This collection and direction of the urine can be does either by passive means such as gravity or capillary force, or by active means such as pumps; (d) reading the urinalysis test results through said at least one opening 14 and analyzing same; and (e) determining whether said analyzed data is indicative of occurrence of a health condition.
- the reading and analyzing of the test results may be done by the user by any suitable means, e.g. by simple comparison, i.e. by visually comparing the results shown in said opening 14 to a data sheet or results-table which interpret the visual results into a prognosis.
- said reading and analyzing may be carried out by using a computer/smartphone after capturing or scanning an image of the results, e.g., with a camera or scanner of a mobile device or a camera and comparing the captured or scanned image with a database, wherein said database may be, e.g., on a cloud or in the mobile device itself, e.g. in a dedicated application.
- the collected results data and/or the analyzed data may also be sent to a veterinarian for further analysis and or follow-up and console.
- said scanned results show up on the mobile device's screen and may be sent to cloud based hosts for incorporation in the pet's health records and overall statistics.
- said scanned test results and/or the analyzed test results are sent to the pet's veterinarian, urgently in case something was found.
- said database may be a remotely located database located in a cloud or a remote computer, and may further contain data of previous test results, of the tested animal as well as of other animals of the same species, for statistical comparison, and generation and updating of pet/animal electronic health records (EHR).
- the urinalysis method of the invention may further comprise a step of sending a response from said remote computer or smartphone to the user showing statistical analysis and/or health recommendations, and/or send alerts due to specific possible health conditions. For instance, if the urine pH level is too high or low, the application may instruct the user to take the animal to the veterinarian and/or perform immediate precautions measures. Another example may be when an abnormal results is obtained, the application may contact the veterinarian for council and/or arrange for an emergency (or regular) appointment.
- said urinalysis device 10 of the invention may comprise a power source and a transmitter, thereby enabling transmitting the test results to the user's mobile device or a remote computer or cloud for analysis, or directly to the animal's veterinarian, which can then send instructions to the pet/animal owner regarding recommendations for nutrition changes, recommendations to perform additional follow-up tests, setting up an appointment with the veterinarian, etc.
- the term "reading" of the urinalysis test results means capturing an image of said analysis strip 13 with a camera or scanner of a mobile device.
- mobile devices are smartphone, tablet, laptop, and a digital camera.
- said captured image is processed using one or more processors contained in the mobile device, e.g. using a dedicated application; or said captured image is transferred to a remote computer/cloud with a processor and a memory for processing; or said captured image is processed using a combination of one or more processors contained in the mobile device and a remote computer/cloud with a processor and a memory for processing.
- the urinalysis device 10 may comprise at least one processor and memory, and the test results are processed within the device 10 and the analyzed results are either displayed thereon or transmitted, e.g., to the user's computer or mobile device and/or to the pet's veterinarian.
- the method of the invention further comprises transmitting data regarding geographical location and time-stamp data of the urinalysis test results.
- the rapid urinalysis method of the invention further comprises a step of processing the transferred test results in said remote computer and returning the processed test results to the user's mobile device or computer, or to the veterinarian's computer/email, via any suitable manner, e.g. via wireless telecommunication.
- the rapid urinalysis method of the invention further comprises a step of statistical analysis of the test results, e.g. for identifying anomalies.
- the urinalysis device 10 and method for rapid urinalysis of animal urine samples according to the invention are based on passive communication, such as a barcode or specific test color arrangement that is scanned or photographed by a camera, e.g., of a mobile device or a digital camera.
- passive communication such as a barcode or specific test color arrangement that is scanned or photographed by a camera, e.g., of a mobile device or a digital camera.
- active communication such as a transmitter located within said urinalysis device 10 that sends the test results to, e.g. said mobile device or a remote computer having a processor and a memory.
- the analysis may be based on a comparison with an external database located, e.g., on a cloud, on said remote computer, or on said mobile device.
- the urinalysis device 10 and method for rapid urinalysis of animal urine samples according to the invention will provide immediate and visible response/results, e.g., by changing the color of said analysis strip 13 or any other detector therein.
- the present invention further provides a non-invasive urinalysis portable urinalysis system, said system comprising: (a) a non-invasive urinalysis portable device 10 of the invention; (b) a mobile device comprising (i) a camera, (ii) one or more processors, and (iii) a memory; (c) a database; and (d) optionally, at least one illumination source.
- said camera is used to capture an image of the test results as appearing in said analysis strip 13.
- said mobile device in the system of the invention is a laptop computer, a smartphone, a tablet, a digital camera or any other device having a camera, a processor and a memory.
- said database may be located either on said mobile device or in a cloud or a remote computer, and may comprise additional statistical data and prior results of both the tested animal and other animals of the same species.
- the urinalysis methods, devices and systems according to the present invention utilize three main types of canine attractants: pheromones, attractive grass like scent, and urine simulating smell (including ammonia).
- the present invention provides a canine attraction composition comprising any combination of: (a) at least one pheromone; (b) at least one of ammonia and urea, or derivatives thereof; and (c) at least one of the following grass scent compounds: ⁇ -ionone (C 13 H 20 O); abietic acid; decarboxylated abietic acid; rosin oil; and methyl salicylate, wherein said composition is suitable for attracting canines and optionally also stimulate urination.
- said at least one pheromone in the canine attraction composition of the invention is: aliphatic n-acetates; aliphatic n-fatty acids; alkyl hydroxybenzoates; phenol and substituted phenols; benzoic acid and derivatives thereof; salicylates; linoleic acid; androgens; estrogens; dimethyl disulphide; hexanal; acetic acid; propanoic acid; 2-methylpropanoic acid; n-butanoic acid; 2-methylbutanoic acid; 3-methylbutanoic acid; n-pentanoic acid; 4-methylpentanoic acid; 2-piperidone; pyrrole; acetophenone; 2-furanmethanol; acetamide; formamide; n-hexanoic acid; dimethyl sulfone; 2-pyrrolidinone; indole; benzeneacetic acid; n-tetradecanoic acid; l-
- said at least one ammonia or urea in the canine attraction composition of the invention is: ammonia, ammonium ion (NH 4 + ), or bicarbonate ion (HC0 3 ⁇ ).
- the canine attraction composition of the invention comprises (a) at least one of benzeneacetic acid, 3-methylbutanoic acid or acetic acid; (b) at least one of ammonia, ammonium ion (NH 4 + ), and bicarbonate ion (HC0 3 ⁇ ); and (c) at least one of ⁇ - ionone, abietic acid, decarboxylated abietic acid, and methyl salicylate.
- the canine attraction composition of the invention may be used as the canine attractant composition of the urinalysis device of the invention, if present.
- the canine attraction composition of the invention may be manufactured in any suitable form, such as liquid, ointment, emulsion, or cream.
- the canine attraction composition of the invention may be used or applied onto or together with the urinalysis device of the invention in any suitable way, including, but not limited to spraying from a pressure spray canister, spreading an ointment or cream, breaking a vial containing the liquid composition, etc.
- the present invention provides a non-invasive urinalysis portable device 10 for the carrying out of rapid diagnostic tests on animal urine samples, comprising: (a) an analysis strip 13 for carrying out diagnostic tests comprising at least one testing reagent and/or sensor designed to detect the presence and/or amount of at least one of: blood, white blood cells, nitrite, glucose, ketones, protein, pH, bilirubin, bacteria, and crystals, wherein said test results can be read from said analysis strip 13; (b) at least one opening 14 for displaying said test results; (c) means 12 for the collection of said urine and forwarding same to said analysis strip 13; and (d) an elongation means 18, optionally as a separate unit to which said device 10 is attached; wherein said non-invasive urinalysis device is designed to be placed underneath said animal as it urinates to collect its urine without disturbing the animal's routine, for forwarding same to said analysis strip 13 for urinalysis, and for analyzing and displaying the uri
- the present invention provides a non-invasive urinalysis portable device 10 for the carrying out of rapid diagnostic tests on canine's urine samples, comprising: (a) an attractant component 15 containing a canine attractant composition as defined above; (b) an analysis strip 13 for carrying out diagnostic tests comprising at least one testing reagent and/or sensor designed to detect the presence and/or amount of at least one of: blood, white blood cells, nitrite, glucose, ketones, protein, pH, bilirubin, bacteria, and crystals, wherein said test results can be read from said analysis strip 13; (c) at least one opening 14 for displaying said test results; (d) means 12 for the collection of said urine and forwarding same to said analysis strip 13; and (e) an adhesive layer 16 or attachment means 17; wherein said noninvasive urinalysis device is designed to be placed onto any surface and at any angle, to attract said canine to urinate thereon, to collect said canine's urine and for forwarding same to said analysis strip
- the pure chemical compounds were purchased or synthesized and were used to prepare different combinations of a canine attractant composition to be tested for their efficiency in attracting canines as well as testing their efficiency in stimulating canine urination.
- pheromones selected from: aliphatic n-acetates, such as n-pentyl acetate; aliphatic n-fatty acids, such as n-butyric acid; alkyl hydroxybenzoates, such as methyl p-hydroxybenzoate and ethyl p-hydroxybenzoate; substituted phenols, such as 2, 6-dichlorophenol; benzoic acid derivatives, such as p-hydroxybenzoic acid, 4-hydroxy-3-n-ethoxybenzaldehyde and methylparaben; salicylates, such as methyl salicylate; linoleic acid (i.e.
- omega-6 fatty acid omega-6 fatty acid
- sex hormones such as naturally occurring and synthetic androgens and estrogens, and their analogs; dimethyl disulphide; hexanal; acetic acid; propanoic acid; 2-methylpropanoic acid; n- butanoic acid; 2-methylbutanoic acid; 3-methylbutanoic acid; n-pentanoic acid; 4- methylpentanoic acid; 2-piperidone; pyrrole; acetophenone; 2-furanmethanol; acetamide; formamide; n-hexanoic acid; dimethyl sulfone; phenol; 2-pyrrolidinone; benzoic acid; indole; benzeneacetic acid; n-tetradecanoic acid; l-methyl-2,4-imidazolidinedione; n-hexadecanoic acid; n-octadecanoic acid; acetic anhydride; ⁇ , ⁇ -d
- benzeneacetic acid, 3-methylbutanoic acid and acetic acid seem to have high attraction potential.
- attractive grass-like scent selected from: ⁇ -ionone (C 13 H 20 O); abietic acid; decarboxylated abietic acid; rosin oil; and methyl salicylate; and
- urine simulating smell selected from: ammonia; ammonium ion (NH 4 + ); and bicarbonate
- a sticker which can be placed / stuck onto a multitude of surfaces
- An analysis strip 13 positioned in a way that enables easy visualization by a camera, said analysis strip 13 comprises a set of reagents testing for elements in the collected urine sample.
- an image of the test results was captured by a camera, e.g. of a mobile device, and analyzed by, e.g., a mobile application or a computer program.
- a canine urine test sticker of the invention was prepared as described in Example 1 above, with the addition of a canine attractant to incentivize the canine to urinate directly onto the sticker.
- the current recommendation is to conduct urinalysis for canines every 6 months. However, this is mainly due to the troubles such as test entails. Accordingly, due to the simplicity and low cost of the present urinalysis device, it will be possible to conduct such urinalysis tests every three months or even every month.
- the canine owner will take one or more of the urinalysis devices of the invention when walk their dog. Once arriving a suitable location, the canine owner can stick or place one urinalysis device onto a suitable platform, such as a wall, a tree, or any other surface, that the dog tends to / is comfortable urinating on. After placing/sticking the urinalysis device, the dog owner releases or applies the canine attractant on the device, if present, to incentivize the dog to urinate specifically on the device.
- the canine owner can simply extends the device under the urinating dog as it urinates.
- a "timer" test will also exist on the device to let the dog owner know when the urinalysis is complete and it is possible to scan the results. Once scanned, the result will show up on the mobile device's screen and may also be sent to cloud based hosts for incorporation in the dog's health records and overall statistics. Optionally, the test results will also be sent to the dog's veterinarian, urgently in case something was found.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Biomedical Technology (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562197014P | 2015-07-26 | 2015-07-26 | |
US62/197,014 | 2015-07-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2017017676A1 true WO2017017676A1 (en) | 2017-02-02 |
Family
ID=57884292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2016/050815 WO2017017676A1 (en) | 2015-07-26 | 2016-07-26 | Device for non-intrusive and automated animal urine tests |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2017017676A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11874269B2 (en) * | 2019-06-06 | 2024-01-16 | Bonnie Goodman | Test pad and system |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001658A (en) * | 1996-09-13 | 1999-12-14 | Diagnostic Chemicals Limited | Test strip apparatus and method for determining presence of analyte in a fluid sample |
US20010008774A1 (en) * | 1987-04-27 | 2001-07-19 | Conopco Inc. | Assays |
US7128352B1 (en) * | 2003-09-15 | 2006-10-31 | Geraldine Phippen | Animal urine specimen collection device |
US7762596B1 (en) * | 2008-02-25 | 2010-07-27 | Gaydos Kelly M | Urine sample retrieval device |
US20100307422A1 (en) * | 2006-10-20 | 2010-12-09 | Nathan Huck | Waste collection mats |
US20110184359A1 (en) * | 2010-01-28 | 2011-07-28 | Dougherty Larry F | Compact Sanitary Specimen Collection Device |
-
2016
- 2016-07-26 WO PCT/IL2016/050815 patent/WO2017017676A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010008774A1 (en) * | 1987-04-27 | 2001-07-19 | Conopco Inc. | Assays |
US6001658A (en) * | 1996-09-13 | 1999-12-14 | Diagnostic Chemicals Limited | Test strip apparatus and method for determining presence of analyte in a fluid sample |
US7128352B1 (en) * | 2003-09-15 | 2006-10-31 | Geraldine Phippen | Animal urine specimen collection device |
US20100307422A1 (en) * | 2006-10-20 | 2010-12-09 | Nathan Huck | Waste collection mats |
US7762596B1 (en) * | 2008-02-25 | 2010-07-27 | Gaydos Kelly M | Urine sample retrieval device |
US20110184359A1 (en) * | 2010-01-28 | 2011-07-28 | Dougherty Larry F | Compact Sanitary Specimen Collection Device |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11874269B2 (en) * | 2019-06-06 | 2024-01-16 | Bonnie Goodman | Test pad and system |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chmelíková et al. | Salivary cortisol as a marker of acute stress in dogs: a review | |
Palme | Monitoring stress hormone metabolites as a useful, non-invasive tool for welfare assessment in farm animals | |
Brandt et al. | Welfare measurements of finishing pigs on the day of slaughter: A review | |
Lees | The sensory physiology of the sheep tick, Ixodes ricinus L | |
Kurien et al. | Experimental animal urine collection: a review | |
Solé et al. | Dietary assessments of adult amphibians | |
US7762596B1 (en) | Urine sample retrieval device | |
JP2013515559A (en) | Detection method | |
Tsokos et al. | Skin and soft tissue artifacts due to postmortem damage caused by rodents | |
Steiner et al. | Randomised prospective study compares efficacy of five different stomach tubes for rumen fluid sampling in dairy cows | |
Garcia et al. | The scavenging patterns of feral cats on human remains in an outdoor setting | |
Vitousek et al. | Stress responsiveness predicts individual variation in mate selectivity | |
Aubé et al. | Assessment of dairy cow welfare at pasture: measures available, gaps to address, and pathways to development of ad-hoc protocols | |
Urbanová et al. | Intensive training technique utilizing the dog’s olfactory abilities to diagnose prostate cancer in men | |
Kaswan et al. | Applications of sensors in livestock management | |
WO2017017676A1 (en) | Device for non-intrusive and automated animal urine tests | |
de Lange et al. | High urinary corticoid/creatinine ratios in cats with hyperthyroidism | |
Nielsen et al. | A nose for lizards; can a detection dog locate the endangered pygmy bluetongue lizard (Tiliqua adelaidensis)? | |
Hintz et al. | Cultured fish epithelial cells are a source of alarm substance | |
EP4358095A2 (en) | On-site detection of parasitic infection of mammals | |
Greville et al. | Evaluating odour and urinary sex preferences in the big brown bat (Eptesicus fuscus) | |
Rushen et al. | The scientific basis of animal welfare indicators | |
Kapustka et al. | Flight distance at pasture and stress response during shearing in alpacas | |
Mottram | Fertility monitoring of cattle | |
Banuvalli et al. | Heat (estrus) detection techniques in dairy farms-a review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16829958 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16829958 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16829958 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 28.08.2018) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 16829958 Country of ref document: EP Kind code of ref document: A1 |